CNX-774
CNX-774 is a potent, orally bioavailable, and irreversible small molecule inhibitor of Bruton's tyrosine kinase (BTK) with sub-nanomolar inhibitory activity. It is a valuable research tool for investigating BTK-dependent signaling pathways in both cellular assays and animal models of autoimmune diseases and B-cell malignancies.
Product Specifications
CAS Number
1202759-32-7
Product Name Alternative
Inhibitor, inhibit, CNX774, CNX-774, CNX 774, autoimmune, Bruton tyrosine kinase, BTK, Btk, B-cell, BCR
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Purity
97.35% (May vary between batches)
Solubility
Ethanol:2 mg/mL (4 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.61 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:93 mg/mL (186.19 mM)
Smiles
CNC (=O) c1cc (Oc2ccc (Nc3ncc (F) c (Nc4cccc (NC (=O) C=C) c4) n3) cc2) ccn1
Molecular Formula
C26H22FN7O3
Molecular Weight
499.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP2-34423H 0.1 mL
Mouse Monoclonal Kappa Light Chain Antibody (SPM558) [HRP]
Sign In for Pricing
View Details sc-433708-LAC-2 200 µL
METTL22 Lentiviral Activation Particles (m2)
Sign In for Pricing
View Details